Kimberly Gentile, VP of Operations at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 5,000 shares at $32.37 ($164K) on 2018-02-01, disclosed to the SEC on 2018-02-02.
Open-market sale of $164k BHVN by VP of Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.37 | 3,352 | $109K | 66.2% |
| 2 | $33.53 | 1,348 | $45K | 27.6% |
| 3 | $33.99 | 300 | $10K | 6.2% |
| Total | $32.78 avg | 5,000 | $164K | 100% |
| Filing → |
| BHVN | SELL | 2020-06-17 | $1.7M | — | Filing → |
| BHVN | SELL | 2020-06-10 | $42K | — | Filing → |
| BHVN | SELL | 2019-11-22 | $2.7M | — | Filing → |